Literature DB >> 17439888

Walking capacities in multiple sclerosis measured by global positioning system odometer.

A Créange1, I Serre, M Levasseur, D Audry, A Nineb, D Boërio, T Moreau, P Maison.   

Abstract

We used a global positioning satellite technology odometer to determine the maximum objective walking distance capacity (MOWD) of patients with multiple sclerosis (MS). The MOWD correlated with Expanded Disability Status Scale (EDSS) score (r(2) =0.41; P <0.0001), the MSWS-12 scale (r(2) =0.46; P <0.0001), time to walk 10 m (r(2) =0.51; P <0.02) and walking speed (r(2) =0.75; P <0.001). Limitation of walking capacities was measurable up to 4550 m, strikingly above the 500-m limit of the EDSS. This objective odometer is a promising tool for evaluation and follow-up of patients with MS.

Entities:  

Mesh:

Year:  2007        PMID: 17439888     DOI: 10.1177/1352458506070667

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  10 in total

1.  Evaluating walking in patients with multiple sclerosis: which assessment tools are useful in clinical practice?

Authors:  Francois Bethoux; Susan Bennett
Journal:  Int J MS Care       Date:  2011

Review 2.  [4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].

Authors:  L Husseini; V I Leussink; B C Kieseier; H-P Hartung
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

3.  The accuracy of a simple, low-cost GPS data logger/receiver to study outdoor human walking in view of health and clinical studies.

Authors:  Bénédicte Noury-Desvaux; Pierre Abraham; Guillaume Mahé; Thomas Sauvaget; Georges Leftheriotis; Alexis Le Faucheur
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

4.  The inter- and intra-unit variability of a low-cost GPS data logger/receiver to study human outdoor walking in view of health and clinical studies.

Authors:  Pierre Abraham; Bénédicte Noury-Desvaux; Marie Gernigon; Guillaume Mahé; Thomas Sauvaget; Georges Leftheriotis; Alexis Le Faucheur
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

5.  Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis.

Authors:  Rémy Phan-Ba; Philippe Calay; Patrick Grodent; Gael Delrue; Emilie Lommers; Valérie Delvaux; Gustave Moonen; Shibeshih Belachew
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

6.  Transparent Quality Optimization for Machine Learning-Based Regression in Neurology.

Authors:  Karsten Wendt; Katrin Trentzsch; Rocco Haase; Marie Luise Weidemann; Robin Weidemann; Uwe Aßmann; Tjalf Ziemssen
Journal:  J Pers Med       Date:  2022-05-31

7.  Measuring Outdoor Walking Capacities Using Global Positioning System in People with Multiple Sclerosis: Clinical and Methodological Insights from an Exploratory Study.

Authors:  Coralie Delahaye; Dorine Chaves; Florian Congnard; Bénédicte Noury-Desvaux; Pierre-Yves de Müllenheim
Journal:  Sensors (Basel)       Date:  2021-05-04       Impact factor: 3.576

8.  Activities-specific balance confidence in people with multiple sclerosis.

Authors:  Ylva Nilsagård; Anna Carling; Anette Forsberg
Journal:  Mult Scler Int       Date:  2012-08-07

9.  The impact of slower walking speed on activities of daily living in patients with multiple sclerosis.

Authors:  M Yildiz
Journal:  Int J Clin Pract       Date:  2012-11       Impact factor: 2.503

10.  Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor function.

Authors:  Meheroz H Rabadi; Kimberly Kreymborg; Andrea S Vincent
Journal:  Drugs R D       Date:  2013-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.